CATALOGO DEI PRODOTTI DELLA RICERCA

BUSTI, Fabiana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.813
EU - Europa 2.395
AS - Asia 1.830
SA - Sud America 347
AF - Africa 42
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.763
SG - Singapore 663
RU - Federazione Russa 641
CN - Cina 635
GB - Regno Unito 554
BR - Brasile 294
SE - Svezia 221
HK - Hong Kong 218
DE - Germania 179
IT - Italia 177
FR - Francia 162
IE - Irlanda 158
FI - Finlandia 136
VN - Vietnam 73
KR - Corea 69
JP - Giappone 39
NL - Olanda 32
UA - Ucraina 32
CA - Canada 31
BE - Belgio 26
ID - Indonesia 22
IN - India 22
AR - Argentina 17
BD - Bangladesh 15
TR - Turchia 15
PL - Polonia 14
ZA - Sudafrica 14
ES - Italia 12
MX - Messico 12
PK - Pakistan 11
IR - Iran 10
TG - Togo 10
AT - Austria 9
EG - Egitto 9
IQ - Iraq 9
VE - Venezuela 8
EC - Ecuador 7
AU - Australia 6
CZ - Repubblica Ceca 6
LT - Lituania 6
CL - Cile 5
GR - Grecia 5
AL - Albania 4
BO - Bolivia 4
CH - Svizzera 4
KG - Kirghizistan 4
PE - Perù 4
UZ - Uzbekistan 4
CO - Colombia 3
EU - Europa 3
HR - Croazia 3
JO - Giordania 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PH - Filippine 2
SA - Arabia Saudita 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GY - Guiana 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 7.438
Salva come PNG Salva come JPEG
Città #
Southend 463
Chandler 416
Singapore 293
Dallas 291
Jacksonville 227
Ashburn 219
Hong Kong 211
Ann Arbor 164
Dublin 156
Moscow 143
Beijing 130
Woodbridge 130
New York 115
Houston 66
Wilmington 66
Lawrence 59
Princeton 59
Los Angeles 58
Verona 52
Helsinki 46
Munich 46
Jinan 43
Boardman 40
Nanjing 40
The Dalles 36
Redondo Beach 34
São Paulo 34
Tokyo 34
Shenyang 27
Brussels 24
Buffalo 23
Turku 21
Ho Chi Minh City 20
Lancaster 20
Redmond 20
London 19
Haikou 18
Santa Clara 18
Seoul 18
Sindelfingen 18
Zhengzhou 18
Falkenstein 17
Hebei 17
Columbus 16
Falls Church 16
Nanchang 16
Ningbo 16
Tianjin 16
Seattle 14
Brooklyn 13
Changsha 13
Milan 13
Jakarta 12
Lappeenranta 12
Nuremberg 12
San Francisco 12
Warsaw 12
Guangzhou 11
Poplar 11
Taiyuan 11
Taizhou 11
Denver 10
Lomé 10
Redwood City 10
Toronto 10
Jiaxing 9
Rio de Janeiro 9
Rome 9
Atlanta 8
Chicago 8
Council Bluffs 8
Fuzhou 8
Hangzhou 8
Norwalk 8
Boston 7
Chennai 7
Dhaka 7
Hanoi 7
Johannesburg 7
Lanzhou 7
Montreal 7
Phoenix 7
Tehran 7
Vienna 7
Villarbasse 7
Amsterdam 6
Fairfield 6
Frankfurt am Main 6
Alexandria 5
Belo Horizonte 5
Bologna 5
Dong Ket 5
Nettuno 5
Orem 5
Stockholm 5
Ankara 4
Belém 4
Bishkek 4
Brno 4
Cagliari 4
Totale 4.471
Salva come PNG Salva come JPEG
Nome #
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 183
A challenging case of abdominal pain associated to Helicobacter pylori infection 172
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 167
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 165
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 163
Identification of new BMP6 pro-peptide mutations in patients with iron overload 153
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 152
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 150
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 148
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 147
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 146
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 146
Altered paraoxonase expression in patients with genetic haemochromatosis. 145
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 144
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 142
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 140
Paraoxonase-1 status in patients with hereditary hemochromatosis 137
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 134
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 132
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 131
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 127
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 124
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 123
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 121
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 119
COBALAMIN DEFICIENCY IN THE ELDERLY 115
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 113
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 113
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 112
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 111
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 110
Modern iron replacement therapy: clinical and pathophysiological insights 108
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 106
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 105
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 104
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 103
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 103
Reduced serum hepcidin levels in patients with chronic hepatitis C 102
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 98
Iron replacement in inflammatory bowel disease: an evolving scenario 95
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 92
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 90
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 87
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 85
Paraoxonase-1 status in patients with hereditary hemochromatosis. 84
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 84
Iron metabolism in infections: Focus on COVID-19 84
Treatment options for anemia in the elderly 82
Hyperferritinemia and diagnosis of type 1 Gaucher disease 79
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 78
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 78
Iron deficiency in the elderly population, revisited in the hepcidin era. 74
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 72
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 71
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 68
Impact of natural Neuromedin-B receptor variants on iron metabolism 68
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 62
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study 62
Hemochromatosis classification: update and recommendations by the BIOIRON Society 62
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 60
ERFE regulation in sickle cell disease: complex but promising 59
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 59
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 58
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 58
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 57
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 57
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 55
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 51
Diagnosis and management of hereditary hemochromatosis: lifestyle modification, phlebotomy, and blood donation 43
New Insights into the Role of Ferroptosis in Cardiovascular Diseases 43
Inflammation and iron homeostasis - what do blood tests mean? 42
Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study 39
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 37
Sparing unnecessary transfusions through patient blood management: time for application also in internal and emergency medicine 37
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 35
Manipulating hepcidin in polycythemia vera 30
Recent Advancement of Hematology: Know, How to Do, Let Know 29
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia 28
Totale 7.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.596
article - articoli 20.689
book - libri 0
conference - conferenze 6.562
curatela - curatele 0
other - altro 345
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 0 0 78 52 18 17 10 18 50 25
2021/2022530 15 159 3 63 20 23 7 28 20 17 50 125
2022/20231.143 67 132 94 198 100 254 22 87 139 4 24 22
2023/2024665 21 36 49 58 54 149 21 48 7 32 96 94
2024/20251.570 82 111 65 255 71 50 94 71 195 94 150 332
2025/20261.979 321 267 356 909 126 0 0 0 0 0 0 0
Totale 7.548